Journal
EXPERIMENTAL HEMATOLOGY
Volume 34, Issue 2, Pages 208-218Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2005.10.009
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL69123, R01 HL57375, R01 HL52813, NIH-HL 07260] Funding Source: Medline
Ask authors/readers for more resources
Objective. Recent studies have reported that bone marrow cells can give rise to tissue fibroblasts. However, the bone marrow cell(s) that gives rise to fibroblasts has not yet been identified. In the present study, we tested the hypothesis that tissue fibroblasts are derived from hematopoietic stem cells (HSCs) in vivo. Methods. These studies were conducted using mice whose hematopoiesis had been reconstituted by transplantation of a clonal population of cells derived from a single enhanced green fluorescent protein (EGFP)-positive HSC in conjunction with murine tumor models. Results. When tumors propagated in the transplanted mice were evaluated for the presence of EGFP(+) HSC-derived cells, two prominent populations of EGFP(+) cells were found. The first were determined to be fibroblasts within the tumor stromal capsule, a subset of which expressed type I collagen mRNA and alpha-smooth muscle actin. The second population was a perivascular cell associated with the CD31(+) tumor blood vessels. Conclusion. These in vivo findings establish an HSC origin of fibroblasts. (C) 2006 International Society for Experimental Hematology. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available